×

ResMed Income from Continuous Operations 2010-2024 | RMD

ResMed annual/quarterly income from continuous operations history and growth rate from 2010 to 2024. Income from continuous operations can be defined as a company's total income or loss before discontinued operations, extraordinary items, preferred stock dividends and accounting change
  • ResMed income from continuous operations for the quarter ending December 31, 2024 was $0.345B, a 65.05% increase year-over-year.
  • ResMed income from continuous operations for the twelve months ending December 31, 2024 was $1.249B, a 40.24% increase year-over-year.
  • ResMed annual income from continuous operations for 2024 was $1.021B, a 13.75% increase from 2023.
  • ResMed annual income from continuous operations for 2023 was $0.898B, a 15.15% increase from 2022.
  • ResMed annual income from continuous operations for 2022 was $0.779B, a 64.26% increase from 2021.
ResMed Annual Income from Continuous Operations
(Millions of US $)
2024 $1,021
2023 $898
2022 $779
2021 $475
2020 $622
2019 $405
2018 $316
2017 $342
2016 $352
2015 $353
2014 $345
2013 $307
2012 $255
2011 $227
2010 $190
2009 $146
ResMed Quarterly Income from Continuous Operations
(Millions of US $)
2024-12-31 $345
2024-09-30 $311
2024-06-30 $292
2024-03-31 $300
2023-12-31 $209
2023-09-30 $219
2023-06-30 $230
2023-03-31 $233
2022-12-31 $225
2022-09-30 $210
2022-06-30 $195
2022-03-31 $179
2021-12-31 $202
2021-09-30 $204
2021-06-30 $195
2021-03-31 $-78
2020-12-31 $180
2020-09-30 $178
2020-06-30 $178
2020-03-31 $163
2019-12-31 $161
2019-09-30 $120
2019-06-30 $69
2019-03-31 $105
2018-12-31 $125
2018-09-30 $106
2018-06-30 $110
2018-03-31 $110
2017-12-31 $10
2017-09-30 $86
2017-06-30 $102
2017-03-31 $88
2016-12-31 $77
2016-09-30 $76
2016-06-30 $83
2016-03-31 $91
2015-12-31 $96
2015-09-30 $83
2015-06-30 $87
2015-03-31 $91
2014-12-31 $91
2014-09-30 $83
2014-06-30 $88
2014-03-31 $90
2013-12-31 $87
2013-09-30 $81
2013-06-30 $73
2013-03-31 $85
2012-12-31 $78
2012-09-30 $71
2012-06-30 $77
2012-03-31 $65
2011-12-31 $63
2011-09-30 $51
2011-06-30 $58
2011-03-31 $53
2010-12-31 $58
2010-09-30 $57
2010-06-30 $53
2010-03-31 $49
2009-12-31 $46
2009-09-30 $42
2009-06-30 $45
2009-03-31 $39
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $32.876B $4.685B
ResMed, Inc. holds a major position as designer, manufacturer, as well as a distributor in the worldwide market for generators, masks, and related accessories for the treatment of sleep-disordered breathing (SDB) and other respiratory disorders. SDB includes obstructive sleep apnea (OSA) and other respiratory disorders that occur during sleep. The company currently has two operating segments, which are the Sleep and Respiratory Care segment and the Software-as-a-Service segment.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $230.058B 28.41
Boston Scientific (BSX) United States $149.209B 40.19
Stryker (SYK) United States $142.084B 30.54
EssilorLuxottica (ESLOY) France $131.854B 0.00
Medtronic (MDT) Ireland $115.249B 16.83
Haleon (HLN) United Kingdom $46.488B 26.39
Lonza Group Ag (LZAGY) Switzerland $44.527B 0.00
GE HealthCare Technologies (GEHC) United States $36.909B 17.98
Agilent Technologies (A) United States $33.351B 22.03
Terumo (TRUMY) Japan $27.805B 39.54
Koninklijke Philips (PHG) Netherlands $23.874B 17.05
Zimmer Biomet Holdings (ZBH) United States $22.530B 14.15
Insulet (PODD) United States $18.442B 78.86
Baxter (BAX) United States $17.557B 12.63
Sunny Optical Technology (SNPTF) China $12.864B 0.00
Smith & Nephew SNATS (SNN) United Kingdom $12.403B 0.00
Demant (WILYY) Denmark $8.048B 0.00
Bio-Rad Laboratories (BIO) United States $6.822B 23.62
Lantheus Holdings (LNTH) United States $6.684B 16.43
Prestige Consumer Healthcare (PBH) United States $4.259B 20.32
Perrigo (PRGO) Ireland $3.826B 10.95
Shandong Weigao Medical Polymer (SHWGF) China $3.459B 0.00
ICU Medical (ICUI) United States $3.405B 29.11
Haemonetics (HAE) United States $3.193B 15.02
Envista Holdings (NVST) United States $2.972B 23.64
QuidelOrtho (QDEL) United States $2.359B 19.76
GN Store Nord (GNNDY) Denmark $2.336B 15.74
LeMaitre Vascular (LMAT) United States $1.893B 43.25
Neogen (NEOG) United States $1.881B 21.67
AtriCure (ATRC) United States $1.577B 0.00
AdaptHealth (AHCO) United States $1.462B 14.08
Kestra Medical Technologies (KMTS) $1.234B 0.00
InMode (INMD) Israel $1.234B 10.31
Green Thumb Industries (GTBIF) United States $1.233B 19.37
BioLife Solutions (BLFS) United States $1.073B 0.00
Phibro Animal Health (PAHC) United States $0.865B 13.27
Evolus (EOLS) United States $0.765B 0.00
Owens & Minor (OMI) United States $0.698B 5.94
CeriBell (CBLL) United States $0.689B 0.00
Curaleaf Holdings (CURLF) Canada $0.601B 0.00
Maravai LifeSciences Holdings (MRVI) United States $0.562B 0.00
Valneva SE (VALN) France $0.545B 0.00
VAREX IMAGING (VREX) United States $0.478B 20.71
Omeros (OMER) United States $0.476B 0.00
Surmodics (SRDX) United States $0.436B 0.00
Capricor Therapeutics (CAPR) United States $0.433B 0.00
SNDL (SNDL) Canada $0.371B 0.00
Cresco Labs (CRLBF) United States $0.354B 0.00
SEMPERIT AG HLD (SEIGY) Austria $0.329B 0.00
Sanuwave Health (SNWV) United States $0.302B 0.00
ZimVie (ZIMV) United States $0.301B 18.00
Viemed Healthcare (VMD) United States $0.288B 26.00
Sanara MedTech (SMTI) United States $0.275B 0.00
Cerus (CERS) United States $0.258B 0.00
Quanterix (QTRX) United States $0.252B 0.00
OraSure Technologies (OSUR) United States $0.252B 0.00
Aurora Cannabis (ACB) Canada $0.247B 43.90
Verano Holdings (VRNOF) United States $0.233B 0.00
Utah Medical Products (UTMD) United States $0.184B 14.19
Biote (BTMD) United States $0.182B 4.16
Brainsway (BWAY) Israel $0.178B 55.71
TriSalus Life Sciences (TLSI) United States $0.168B 0.00
High Tide (HITI) Canada $0.153B 0.00
Canopy Growth (CGC) Canada $0.144B 0.00
TerrAscend (TSNDF) Canada $0.140B 0.00
Organigram Holdings (OGI) Canada $0.128B 0.00
Jin Medical (ZJYL) China $0.116B 0.00
FitLife Brands (FTLF) United States $0.112B 13.99
Quipt Home Medical (QIPT) United States $0.100B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.087B 0.00
Fonar (FONR) United States $0.087B 12.18
MacroGenics (MGNX) United States $0.080B 0.00
Veru (VERU) United States $0.072B 0.00
Zynex (ZYXI) United States $0.067B 24.44
United Health Products (UEEC) United States $0.066B 0.00
Exagen (XGN) United States $0.064B 0.00
InterCure (INCR) Israel $0.064B 0.00
Jushi Holdings (JUSHF) United States $0.059B 0.00
Cytosorbents (CTSO) United States $0.055B 0.00
Apyx Medical (APYX) United States $0.052B 0.00
Modular Medical (MODD) United States $0.044B 0.00
ImmuCell (ICCC) United States $0.043B 0.00
United-Guardian (UG) United States $0.041B 12.66
Rockwell Medical (RMTI) United States $0.038B 56.50
Safety Shot (SHOT) United States $0.027B 0.00
INLIF (INLF) $0.021B 0.00
Nephros (NEPH) United States $0.018B 0.00
Allurion Technologies (ALUR) United States $0.015B 0.00
Cellectar Biosciences (CLRB) United States $0.015B 0.00
Flora Growth (FLGC) United States $0.012B 0.00
Trinity Biotech (TRIB) Ireland $0.010B 0.00
NeuroMetrix (NURO) United States $0.009B 0.00
Meihua Medical Technologies (MHUA) China $0.008B 0.00
Innovative Eyewear (LUCY) United States $0.006B 0.00
Agape ATP (ATPC) $0.005B 0.00
IM Cannabis (IMCC) Canada $0.003B 0.00
Senestech (SNES) United States $0.003B 0.00
Akanda (AKAN) United Kingdom $0.002B 0.00
GlucoTrack (GCTK) United States $0.002B 0.00
Sharps Technology (STSS) United States $0.000B 0.00
InVivo Therapeutics Holdings (NVIVQ) United States $0.000B 0.00